ANDREW PETTIT: Open Payments
NPI 1487200853 · TAYLORSVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 45 payments from 20 companies in 2025. Trend: 2023 $886 · 2024 $811 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $184 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Boston Scientific Corporation | 1 | $76 |
| Lilly USA, LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Exact Sciences Corporation | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Gilead Sciences, Inc. | 2 | $33 |
| Smith+Nephew, Inc. | 2 | $28 |
Products named: VRAYLAR, General - Pain Management, AIRSUPRA, QULIPTA, MOUNJARO, REXULTI, Cologuard Collection Kit, UBRELVY.
Industry payments across UT — which companies pay providers there.
